Harvard Bioscience, Inc. (NasdaqGM:HBIO) is looking for acquisitions. James Green, Chairman of the Board, President and Chief Executive Officer said, "I've always thought that as we have a clean year this year, really get to our targets that we're expecting for next year to be at our long-term targets, our balance sheet is going to be much stronger. You can see what we've done with debt.

We're going to be in a much better position to be able to look at acquisitions. I'm accustomed to looking at not just acquisitions, but also licensing structures at products that will help me really fill out this portfolio as I go into and start to penetrate, you got bioproduction penetration. That's an area that has real interest that I might -- I'll be looking at areas there and whether that's acquisitions or whether that's licensing or some collaborations".